SCHEMBL9820114

SCHEMBL9820114

OC[C@H]1O[C@H](O[C@@]2(O)O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O

nearest known ligand 0.55

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
CDK1 P06493 1/20 0.53
CCNB1 P14635 1/20 0.53
MEN1 O00255 1/20 0.52
KMT2A Q03164 1/20 0.52
TYR P14679 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.43
GAA P10253 1/20 0.42
MAPT P10636 1/20 0.42
CA2 P00918 1/20 0.42
CA9 Q16790 1/20 0.42
POLB P06746 1/20 0.41
PTPN1 P18031 1/20 0.41
SYNJ2 O15056 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27540220 1.00 CDK1 (0.53) CDK1CCNB1MEN1KMT2ATYR
SCHEMBL27681755 1.00 CDK1 (0.53) CDK1CCNB1MEN1KMT2ATYR
SCHEMBL27532642 1.00 CDK1 (0.53) CDK1CCNB1MEN1KMT2ATYR
SCHEMBL29009306 1.00 CDK1 (0.53) CDK1CCNB1MEN1KMT2ATYR
SCHEMBL29265670 1.00 CDK1 (0.53) CDK1CCNB1MEN1KMT2ATYR
SCHEMBL1979416 1.00 CDK1 (0.53) CDK1CCNB1MEN1KMT2ATYR
SCHEMBL27437550 1.00 CDK1 (0.53) CDK1CCNB1MEN1KMT2ATYR
SCHEMBL9711100 1.00 CDK1 (0.53) CDK1CCNB1MEN1KMT2ATYR
SCHEMBL2039316 1.00 CDK1 (0.53) CDK1CCNB1MEN1KMT2ATYR
SCHEMBL27522465 1.00 CDK1 (0.53) CDK1CCNB1MEN1KMT2ATYR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0156347-B1 GLYCOSIDES OF RESOFURIN DERIVATIVES, METHOD FOR THEIR PREPARATION AND THEIR USE IN THE DETERMINATION OF THE ACTIVITY OF GLYCOSIDASES Roche Diagnostics GmbH (DE) 1991-09-04 EP disclosed
EP-0128097-A1 Immunostiumulating derivatives, their preparation and their use as medicines Etablissement Public dit: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 1984-12-12 EP disclosed